{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:59:36Z","timestamp":1778047176686,"version":"3.51.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate the changes of blood circulation within the polypoidal lesions by OCT angiography in eyes with polypoidal choroidal vasculopathy after combination therapy with aflibercept and photodynamic therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A total of 46 eyes from 46 patients who underwent the combination therapy for polypoidal choroidal vasculopathy were followed for more than 6 months. OCT angiography, covering an area 6 mm<jats:sup>2<\/jats:sup> \u00d7 6 mm<jats:sup>2<\/jats:sup> including the macula, were performed at baseline, 2 weeks, and 3 months and 6 months post-treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The subretinal fluid resolved within 3 months after treatment in 44 eyes (95.7%), and 27 eyes (58.7%) showed no recurrence, with no additional treatment. Seventeen eyes (37.0%) showed recurrence, and two eyes (4.3%) showed poor response. On OCT angiography at 2 weeks after treatment, flow signals were detected in 3 of 27 eyes (11.1%) without recurrence and in 8 of 19 eyes (42.1%) with recurrence or poor responses. A detectable flow signal at 2 weeks was significantly associated with recurrence or poor response (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.032).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Persistent flow signals within polyps on OCT angiography at 2 weeks after combination therapy suggest less effectiveness of the initial treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003395","type":"journal-article","created":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T22:01:35Z","timestamp":1640556095000},"page":"942-948","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["ASSOCIATION OF FLOW SIGNALS WITHIN POLYPS ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WITH TREATMENT RESPONSES AFTER COMBINATION THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5991-3846","authenticated-orcid":false,"given":"Hisashi","family":"Fukuyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Komuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumi","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/IAE.0b013e318188c839","article-title":"A classification system for polypoidal choroidal vasculopathy","volume":"29","author":"Cackett","year":"2009","journal-title":"Retina"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ophtha.2013.12.037","article-title":"LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy","volume":"121","author":"Oishi","year":"2014","journal-title":"Ophthalmology"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the planet study: a randomized clinical trial","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/archopht.1995.01100060136048","article-title":"Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin","volume":"113","author":"Miller","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/clm.1996.14.323","article-title":"Vascular effects of photodynamic therapy","volume":"14","author":"Fingar","year":"1996","journal-title":"J Clin Laser Med Surg"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0161-6420(96)30675-1","article-title":"Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys","volume":"103","author":"Kramer","year":"1996","journal-title":"Ophthalmology"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","article-title":"Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the asia-pacific ocular imaging society PCV Workgroup","volume":"128","author":"Cheung","year":"2021","journal-title":"Ophthalmology"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ophtha.2014.01.034","article-title":"Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration","volume":"121","author":"Jia","year":"2014","journal-title":"Ophthalmology"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajo.2015.04.021","article-title":"Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study","volume":"160","author":"Ishibazawa","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"Oct324","DOI":"10.1167\/iovs.15-18898","article-title":"Characteristics of polypoidal choroidal vasculopathy evaluated by optical coherence tomography angiography","volume":"57","author":"Tomiyasu","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"Oct526","DOI":"10.1167\/iovs.15-18955","article-title":"Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography","volume":"57","author":"Wang","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.oret.2017.11.016","article-title":"Indocyanine green dye filling time for polypoidal lesions in polypoidal choroidal vasculopathy affects the visibility of the lesions on OCT angiography","volume":"2","author":"Fukuyama","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1097\/IAE.0000000000002760","article-title":"Diagnostic characteristics of polypoidal choroidal vasculopathy based on b-scan swept-source optical coherence tomography angiography and its interrater agreement compared with indocyanine green angiography","volume":"40","author":"Fujita","year":"2020","journal-title":"Retina"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ajo.2020.05.017","article-title":"A comparison study of polypoidal choroidal vasculopathy imaged with indocyanine green angiography and swept-source optical coherence tomography angiography","volume":"217","author":"Kim","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ophtha.2017.08.030","article-title":"Natural history of subclinical neovascularization in nonexudative age-related macular degeneration using swept-source OCT angiography","volume":"125","author":"de Oliveira Dias","year":"2018","journal-title":"Ophthalmology"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/IAE.0000000000001776","article-title":"Comparison of optical coherence tomography angiographic changes after anti-vascular endothelial growth factor therapy alone or in combination with photodynamic therapy in polypoidal choroidal vasculopathy","volume":"38","author":"Teo","year":"2018","journal-title":"Retina"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2017.12.005","article-title":"Long-term progression of type 1 neovascularization in age-related macular degeneration using optical coherence tomography angiography","volume":"187","author":"Xu","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10384-020-00734-3","article-title":"Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy","volume":"64","author":"Komuku","year":"2020","journal-title":"Jpn J Ophthalmol"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41598-018-37384-y","article-title":"Characterizing branching vascular network morphology in polypoidal choroidal vasculopathy by optical coherence tomography angiography","volume":"9","author":"Huang","year":"2019","journal-title":"Sci Rep"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/IAE.0000000000002228","article-title":"Improved detection and diagnosis of polypoidal choroidal vasculopathy using a combination of optical coherence tomography and optical coherence tomography angiography","volume":"39","author":"Cheung","year":"2019","journal-title":"Retina"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00417-020-04924-0","article-title":"Clinical characteristics of super stable polypoidal choroidal vasculopathy after initial remission with anti-VEGF monotherapy","volume":"259","author":"Choi","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/aos.13364","article-title":"Identification and clinical role of choroidal neovascularization characteristics based on optical coherence tomography angiography","volume":"95","author":"Sulzbacher","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","article-title":"Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment","volume":"33","author":"Koh","year":"2013","journal-title":"Retina"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"e110667","DOI":"10.1371\/journal.pone.0110667","article-title":"Combined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studies","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"e765","DOI":"10.1111\/aos.13130","article-title":"Three-year visual outcomes of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy","volume":"94","author":"Sakai","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"e0241230","DOI":"10.1371\/journal.pone.0241230","article-title":"Flow signal change in polyps after anti-vascular endothelial growth factor therapy","volume":"15","author":"Chang","year":"2020","journal-title":"PLoS One"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bjo.2007.132357","article-title":"Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy","volume":"92","author":"Wakabayashi","year":"2008","journal-title":"Br J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:01:09Z","timestamp":1749319269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003395","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}